• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Mike Fazio Highlights Interest in Data and Benchmarking in OCM

Video

Practices participating in the Oncology Care Model (OCM) have been interested in understanding the data and what it tells them about how to focus their efforts, said Mike Fazio, senior vice president of client services, Archway Health.

Practices participating in the Oncology Care Model (OCM) have been interested in understanding the data and what it tells them about how to focus their efforts, said Mike Fazio, senior vice president of client services, Archway Health.

Transcript

What are some key lessons that practices participating in OCM are learning?

So, the data availability has been a tremendous learning experience for all of our customers. It’s a lot of information. So, taking small steps to understand where to focus with that data is something they’ve all been able to do. And so, things like [emergency department] utilization reduction. How to do that? Really the data informs them where they need to focus their efforts. Same with hospitalizations and same with using palliative and hospice care at the end of life. And then there’s the drug spend and doing comparisons there.

So, benchmarking has been an area of interest of all of our customers, and we do that in a blinded way, but identifying the top performers, even overall within the program and individual by disease looking at that. And what are they doing differently? Everyone is interested in that. What is that top performing practice doing and how do I make that a process in my practice? And so that’s something we’ve seen a lot of interest in. And that’s a great avenue for discovery in a model like OCM, which is a pilot, and this is the time to learn and test those things.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.